You are on Trendlyne India. Click here to go to United States website or make India as your default
  1. Stocks
  2. Vaishali Pharma Ltd.
  3. Swot
swot-logo

Vaishali Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Vaishali Pharma Ltd. has 8 Strengths, 12 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Expensive Performers (DVM)

PEG lower than Industry PEG

Relative Outperformance versus Industry over 1 Week

Company with Low Debt

Increasing Revenue every quarter for the past 2 quarters

Book Value per share Improving for last 2 years

Company with Zero Promoter Pledge

Top Gainers

PE higher than Industry PE

High PE (PE > 40)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Poor cash generated from core business - Declining Cash Flow from Operations for last 2 years

Major fall in TTM Net Profit

Weak Momentum: Price below Short, Medium and Long Term Averages

Increasing Trend in Non-Core Income

RSI indicating price weakness

Highest fall from 52 Week High

Stocks Underperforming their Industry Price Change in the Quarter

Expensive Performers (DVM)

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)